loading

Press Releases

 

INVITRO INTERNATIONAL, A PIONEER IN NON-ANIMAL TESTING ALTERNATIVES FOR OCULAR AND DERMAL TOXICITY RELEASES FY Q1 2021 RESULTS

February 10, 2021

INVITRO INTERNATIONAL, A PIONEER IN NON-ANIMAL TESTING ALTERNATIVES FOR OCULAR AND DERMAL TOXICITY RELEASES FY 2020 RESULTS

December 7, 2020

INVITRO’S OCULAR IRRITECTION® REACHES FINAL STAGE OF OECD’S TEST METHOD ADOPTION

November 15, 2017

INVITRO INTERNATIONAL REPORTS FY 2016 A YEAR OF SOLID PROGRESS WITH AN UNUSUAL LOOK

January 31, 2017

INVITRO INTERNATIONAL REPORTS OUTSTANDING FY 2015 FINANCIAL RESULTS, AND CORE TECHNOLOGY REGULATORY PROGRESS

February 2, 2016

INVITRO INTERNATIONAL REPORTS POSITIVE FINANCIAL IMPACT OF RELOCATION; FY 2014 FINANCIAL RESULTS, AND 1ST QUARTER FY 201 SALES JUMP

February 3, 2015

INVITRO INTERNATIONAL REPORTS IMPORTANT FY 2013 & Q1 FY 2014 REGULATORY PROGRESS, SMALL NET PROFITS

January 22, 2014

INVITRO INTERNATIONAL REPORTS POSITIVE 1ST QUARTER FY 2013 FOLLOWING FY 2012 DECLINE

January 23, 2013

INVITRO INTERNATIONAL REPORTS RETURN TO INCREASED SALES & PROFITS IN FY 2011

January 18, 2012

INVITRO INTERNATIONAL REPORTS 1ST QUARTER FY 2010 SALES JUMP 24% FOLLOWING FY 2010/2009 DECLINE

January 19, 2011

INVITRO INTERNATIONAL FY 2009 SALES REACH HIGHEST LEVEL IN 12 YEARS

January 13, 2010

INVITRO INTERNATIONAL RECORDS HEALTHY FY ’08 SALES & PROFIT RESULTS

January 13, 2009

INVITRO INTERNATIONAL POSTS FY ’07 SOLID SALES GAIN & RECORD PROFITS

December, 2007

INVITRO INTERNATIONAL POSTS EARLY FY ’07 SALES & PROFIT GAINS FOLLOWING MODEST FY ’06 RESULTS

March, 2007

INVITRO INTERNATIONAL POSTS FY ’05 PROFIT ON SOLID SALES GAIN

February, 2006

INVITRO INTERNATIONAL SALES ADVANCE MODESTLY BUT FY ’04 LOSSES DISAPPOINT

February, 2005

INVITRO INTERNATIONAL SALES ADVANCE IN ITS PROFITABLE FY 2003; NEW GLOBAL PARTNERSHIP BEGINS

November, 2003

INVITRO INTERNATIONAL PROFITABLE IN FIRST QUARTER 2003 FOLLOWING A DISAPPOINTING 2002

January, 2003

INVITRO INTERNATIONAL FINISHES FY 2001 WITH SMALL PROFIT DESPITE ANNUAL SALES DECLINE

January, 2002 — Sales jump in First Quarter 2002

INVITRO INTERNATIONAL’S 1st HALF FY 2001 PRODUCES NET PROFIT VS. PRIOR YEAR LOSS;

May, 2001 — Website Database Sales To Start Soon

INVITRO INTERNATIONAL’S Y2K RESULTS

January, 2001 — Feature added global government support

INVITRO INTERNATIONAL REPORTS 1ST HALF 2000 OPERATING INCOME ON INCREASED SALES

May, 2000 — U.S. Government Agency Approvals expected to brighten future

INVITRO INTERNATIONAL POSTS 4TH CONSECUTIVE PROFITABLE QUARTER

Jan, 2000 — Full year ’99 sales up 16%, net profit at 9.4%

INVITRO INTERNATIONAL POSTS 3RD CONSECUTIVE PROFITABLE QUARTER

Aug, 1999 — Company also receives Corrositex endorsement from government sponsored science panel

INVITRO INTERNATIONAL REPORTS SECOND QUARTER PROFITS

May, 1999 — Sales & Cash Increase 6th Consecutive Quarter

INVITRO INTERNATIONAL REPORTS FIRST QUARTER PROFITABLE

February, 1999 — Sales & Cash Increase 5th Consecutive Quarter

INVITRO INTERNATIONAL REPORTS FOURTH QUARTER PROFITABLE, BEFORE INVENTORY WRITE OFF

January, 1999 — Sales & Cash Increase 4th Consecutive Quarter

INVITRO SALES, CASH INCREASE AGAIN; MERGER PLANS UPDATE

July, 1998 — Revenues and cash increase third consecutive quarter

INVESTOR RELATIONS FIRM SIGNED

June, 1998 — Makenna Delaney & Sullivan, Inc. to assist the firm

FINANCIAL HIGHLIGHTS

May, 1998 — Revenue Increases 2% Over Previous Quarter

PRESIDENT’S LETTER

January, 1998 — Lowest Quarterly Loss Since Becoming A Public Company

FINANCIAL HIGHLIGHTS

January, 1998 — First Quarter ended December 31, 1997

FINANCIAL HIGHLIGHTS

November, 1997 — Fiscal Year Ended September 30, 1997

INVITRO INTERNATIONAL REPORTS THIRD QUARTER RESULTS

August 15, 1997 — Company Announces Lowest Quarterly Loss and Expands Merger Options

INVITRO INTERNATIONAL REPORTS SECOND QUARTER RESULTS

May 15, 1997 — Company Signs Merger Letter Of Intent With Miragen

INVITRO INTERNATIONAL SIGNS MERGER LETTER OF INTENT

March 3, 1997 — IVI announces it has signed a letter of intent to merge with Shenyang International Inc.

INVITRO INTERNATIONAL REPORTS FIRST QUARTER RESULTS

February 4, 1997 — Board Of Directors Defer Decision To Implement 1-For-10 Reverse Stock Split Recently Approved By Shareholders

INVITRO INTERNATIONAL REPORTS YEAR-END RESULTS

December 18, 1996 — Net Annual Loss Lowest In Company’s Public History

InVitro International
330 E. Orangethorpe Ave., Suite D
Placentia, CA 92870

800-2-INVITRO (800-246-8487)
949-851-8356 (International callers)
949- 851-4985 Fax

invitro@invitrointl.com